Gregory Matthew R, Liaqat Khurram, Treat Kayla, Haider Kathryn M, Vetrini Francesco, Conboy Erin
Indiana University School of Medicine, Riley Hospital for Children, Indianapolis, Indiana, USA.
Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Case Rep Genet. 2025 May 27;2025:3466358. doi: 10.1155/crig/3466358. eCollection 2025.
Achromatopsia (ACHM) (MIM: 262300) is an autosomal recessive disorder characterized by reduced visual acuity and color blindness. In this report, we review the case of a 14-year-old male patient diagnosed with achromatopsia with a history of retinal dystrophy, cone dysfunction with normal dark-adapted response on ERG, congenital nystagmus, farsightedness, and astigmatism. The diagnostic exome sequencing previously revealed a single maternally inherited pathogenic variant (c.1148delC, p.(T383lfs∗13). Following enrollment in the Undiagnosed Rare Disease Clinic (URDC) at Indiana University School of Medicine (IUSM), genome sequencing (GS) identified a second known variant c.1663-1205G > A p.(Gly555Leufs∗33), which was classified as likely pathogenic. Identification of this variant in the patient provided the evidence needed for a molecular diagnosis and ended a 15-year diagnostic odyssey for the patient and his family. With a diagnosis, the patient is eligible for gene therapy and qualifies for the state-run Vocational Rehabilitation Program and bioptic driving.
全色盲(ACHM)(MIM:262300)是一种常染色体隐性疾病,其特征为视力下降和色盲。在本报告中,我们回顾了一名14岁男性患者的病例,该患者被诊断为全色盲,伴有视网膜营养不良病史、视网膜电图显示暗适应反应正常的视锥功能障碍、先天性眼球震颤、远视和散光。先前的诊断性外显子组测序揭示了一个单一的母系遗传致病变异(c.1148delC,p.(T383lfs∗13))。在印第安纳大学医学院(IUSM)的未确诊罕见病诊所(URDC)登记后,基因组测序(GS)确定了第二个已知变异c.1663-1205G > A p.(Gly555Leufs∗33),该变异被归类为可能致病。在该患者中鉴定出此变异为分子诊断提供了所需证据,并结束了患者及其家人长达15年的诊断历程。有了诊断结果,该患者有资格接受基因治疗,并符合国家运营的职业康复计划和助视器驾驶的条件。